Verona Pharma plc (VRNA) Reports In-Line Q3 EPS

Verona Pharma plc (NASDAQ: VRNA) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07).

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
• Vermilion Energy gets TSX approval to repurchase up to 10% of float
• Rambus launches DDR5 9600 server RDIMM chipset for AI workloads